Todos Medical Appoints Dr. Lauren Chung to its Board of

New Post Public Reply Private Reply Replies (1) Message Board
Mauibound
450
Todos Medical Appoints Dr. Lauren Chung to its Board of Directors

BY GlobeNewswire
— 7:30 AM ET 04/17/2020

 Receives valuation of Alzheimer’s disease blood diagnostic LymPro Test Retains Donohoe Advisors to assist with Nasdaq CM™ listing process

REHOVOT, Israel, SINGAPORE and NEW YORK, NY, April 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --Todos Medical Ltd. ( TOMDF Loading...) , a commercial in vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders as well as point-of-care and lab-based tests for COVID-19, announces the appointment of Lauren Chung, Ph.D. to its Board of Directors. This appointment increases the size of the Todos Medical Board to 7 Directors, including 2 independent Directors.  Dr. Chung has been named lead independent Director, and will serve as Chair of both the Compensation Committee and the Nomination and Governance Committee.

Todos Medical ( TOMDF Loading...) also announces it has received the independent third-party valuation report required to complete the full acquisition of its joint venture Breakthrough Diagnostics, Inc. that is developing the proprietary immune-based Alzheimer’s disease blood diagnostic LymPro Test. Additionally, the Company announces that it has retained Donohoe Advisors to assist with its proposed listing on the Nasdaq CM™ national stock exchange in the United States.

“I am excited to join Todos at this key time in its growth trajectory,” said Dr. Chung. “With its recent entry into the COVID-19 testing space, Todos has taken a thoughtful, incremental approach to the market by focusing on the underlying biology of the disease as the field’s understanding is evolving, and how this will impact biomarker activation and relationships.  This will help to inform physicians on how to use the tools we will be making available to diagnose, monitor and ultimately evaluate patient response to new therapies as they begin to enter the marketplace.”

She added, “This approach was born out of Todos Medical’s approach to Alzheimer’s disease given the lack of easy-to-use, effective diagnostic tools in that indication. With the enormous impact of COVID-19 and Alzheimer’s disease on the United States economy, Todos grasps the importance of sound science and following the data. I believe this approach will position the Company well for both near- and long-term success, and I look forward to assisting the Company in achieving its objective.”

Dr. Chung is the founder and CEO of MINLEIGH LLC, which is focused on identifying, evaluating and partnering with companies for investments and strategic, operational, and commercial opportunities. She has over 20 years of healthcare investment management, investment banking and advisory experience, and is currently a venture partner at Yozma Group Asia headquartered in South Korea. 

Dr. Chung was a managing director in Healthcare Research at WestPark Capital. Previously, she was a co-founder of Tokum Capital Management, a global healthcare fund, which merged with Perella Weinberg Partners. Prior to that, Dr. Chung managed healthcare investment portfolios at RBR Capital, Kingdon Capital and Pequot Capital. Earlier in her career, Dr. Chung was a research scientist doing cutting-edge work in neurodegenerative and genetic disorders at Massachusetts General Hospital/Harvard Medical School and Boston Children’s Hospital. Dr. Chung has published in many leading peer-reviewed scientific journals. 

As a current and former director of public and private companies, Dr. Chung brings a valuable perspective for the Company’s strategy and operations, as well as extensive scientific insights. Dr. Chung serves on the business review board of the Alzheimer’s Drug Discovery Foundation. Dr. Chung holds a Ph.D. in neuropathology from Columbia University-College of Physicians & Surgeons, and a BA with honors in Biochemistry and Economics from Wellesley College.

“We have been working with Dr. Chung for some time on an informal basis, and she has provided significant insight and guidance on positioning the Company for future growth,” said Gerald E. Commissiong, President & CEO of Todos Medical ( TOMDF Loading...). “We believe Alzheimer’s disease is effectively cancer of post-mitotic neurons, and this is the basis for aligning Todos’ cancer platform with the LymPro Alzheimer’s platform. Given Dr. Chung’s extensive background in the scientific and business communities in the Alzheimer’s space, and broad reach into the Asian capital markets, now is the time to bring Lauren on board as we build the Company’s profile as a leader in immune-based diagnostics for cancer, Alzheimer’s disease and COVID-19 in preparation for national stock exchange listing.”

https://www.globenewswire.com/news-release/20...ctors.html

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 33

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Fermi Board Fight Tests Texas Governance Standards Again

Updated Category News Views 93

A boardroom rulebook is supposed to restrain power, not become a trapdoor under shareholders’ feet. That is the ugly governance question hanging over Fermi after the Texas Business Court dismissed Toby Neugebauer’s challenge to the company’s 70% supermajority bylaw. Neugebauer, Fermi’s co-founder and largest shareholder, says he will appeal. Frankly, he has every...

Continue Reading
Trade Secret Damages Turn on Corporate Intent Evidence

Updated Category News Views 72

Suspicion may rattle a courtroom, but it apparently does not always loosen the jury’s purse strings. That is the useful, slightly sobering takeaway from DOAR’s new national study on damages in trade secret disputes, released November 20, 2026. Jurors, according to the report, draw a meaningful line between an employee carrying experience to a new job and a company...

Continue Reading
Subsplash Builds a Broader Church Software Stack in 2026

Updated Category News Views 91

Church software has spent too many years behaving like a junk drawer, and Subsplash is plainly trying to replace it with one working system. The company used its November 18 Product Event in Dallas to show off releases from 2026 and preview two additions: Communications, due in December, and Subsplash Intelligence, targeted for early 2027. A Serious Push Beyond the Church...

Continue Reading
NEWWAVE Turns 15 and Chases a Bigger Tech Partner Role

Updated Category News Views 97

Fifteen years is about when an outsourced engineering shop has to prove it can be more than extra hands on a keyboard. NEWWAVE’s new identity and “Trusted Technology Partner” positioning are an attempt to make that jump: from carrying out software work to helping clients decide what work ought to be done, then sticking around after launch. It is a sensible ambition,...

Continue Reading
Northgate’s Stanton Opening Puts Community Work First

Updated Category News Views 51

A 55,721-square-foot grocery opening can look like ordinary retail churn until you notice where the money and attention are landing. Northgate González Market’s new Stanton location arrives ahead of Thanksgiving, yes, but the more telling detail is the company’s decision to pair a major store launch with 375 jobs and more than $30,000 directed toward families,...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 45

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 158

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading
Industrial Air Compressors: Fix, Rebuild, or Replace

Updated Category News Views 68

A compressor’s ugliest invoice is rarely the one from the service technician. It is the one nobody sees at first: a stalled production line, missed output, overtime, wasted electricity, and a maintenance crew chasing the same machine again next month. Pam Mahood of Waterloo, Iowa-based Compressed Air & Equipment Co. puts the decision where it belongs—not on the price...

Continue Reading
U.S. Employers Signal a Deeper Multilingual Skills Gap

Updated Category News Views 70

A language gap rarely makes the loudest noise in an earnings call, yet it can quietly wreck a sales effort, a hiring plan, or a customer relationship. ACTFL's updated 2026 employer study puts some hard edges around that problem: U.S. businesses say multilingual capability is not a nice cultural accessory. It is increasingly part of operating the business. Demand Has Moved...

Continue Reading

Top 5 Most Recently Viewed Articles

Analysis of Smart Stadium Market Dynamics and Trends

Updated Category News Views 100

Overview of the Smart Stadium Market Custom Market Insights has released an in-depth study on the Smart Stadium Market within its research database. This report sheds light on current market trends and insights, focusing on components like Software and Services, as well as applications such as Digital Content Management and Stadium and Public Security. In 2023, the market...

Continue Reading
Transforming $1000 in ProShares UltraPro QQQ: A Decade of Growth

Updated Category News Views 233

Transforming a $1000 Investment into a Small Fortune ProShares UltraPro QQQ (NASDAQ:TQQQ) has shown impressive performance in the stock market over the decade. Investors who placed their confidence in this fund have enjoyed remarkable annualized returns of 36.49%. This performance surpasses market averages by a significant margin, indicating a powerful investment choice...

Continue Reading
Trifork Group Reports Executive Transactions Announcing Shares

Updated Category News Views 217

Trifork Group's Recent Executive Transactions As part of its ongoing commitment to transparency, Trifork Group AG has reported significant transactions involving its executive team. These disclosures, in accordance with the Market Abuse Regulation Article 19, inform stakeholders about the exchange of fixed salaries for shares, a practice that aligns executive interests...

Continue Reading
Understanding Disclosure Requirements for Assura Plc's Shares

Updated Category News Views 178

Understanding Disclosure Requirements for Assura Plc's Shares Disclosures in the financial market are vital for transparency, especially for companies like Assura Plc. This article provides an insightful overview of the recent public opening position disclosures and relevant securities that attract attention in the market landscape. Key Details of the Disclosure The...

Continue Reading
The Importance of Kindness: Celebrating Everyday Good Deeds

Updated Category News Views 375

Understanding Kindness and Its Impact For educators and students, kindness is a fundamental value that shapes everyday interactions. Malik Singleton, a student support coordinator at a partner school, believes that even small acts of kindness can leave a lasting impression on individuals and the community. Although we celebrate kindness on specific days, its essence is...

Continue Reading